Synairgen Share Discussion Threads

[rmc100] 20/7/2020 19:55

What's the next big thing then gents, I sold out at 150 this morning. Enough profit for me and trying to de risk my portfolio

[hazl] 20/7/2020 19:50

Loads of coverage I saw it too on BBC NEWS AT 6.

But ADVRN Leader board?

No!

finished nearly 500% up.

[hazl] 20/7/2020 19:47

'Synairgen's SNG001 shows strong promise in COVID-19 trial'
20th July 202








economictimes.indiatimes.com › business ›

even in India

[jonnynixon] 20/7/2020 19:47

Did not see anything to do with sng only the hype of vaccines and the Oxford trials

[borg45] 20/7/2020 19:20

No typical MSM anything good Britain does is frowned upon by the leftwing melts running the media

[sideshowbull] 20/7/2020 19:20

Jeez who would have thought! ;-)


That spike reminds me of the good old days of AIM!


BWTFDIK

[dovey21] 20/7/2020 19:17

>>>> Jonny

It was on the 6pm BBC news! I'd say that's a success.?

[jonnynixon] 20/7/2020 19:13

Not getting the coverage it deserves. Oxfords future vaccine appears more news worthy! Almost like uk media trying to keep this on the down low. Are there any rumours on takeover talks or deals being done?

[tidy 2] 20/7/2020 19:07

SNG Been all over the news. BBC ITV even in parliament. Seems very encouraging for all respiratory illnesses not just cv. The AZN vaccine is basically an adapted flu vaccine they have fast tracked but still wouldn't be ready until next year which will likely be a completely different strain of cv by then same as is the case with flu vaccines. Not all encompassing

[hazl] 20/7/2020 19:03

“The results confirm our belief that interferon beta, a widely known drug that, by injection, has been approved for use in a number of other indications, has huge potential as an inhaled drug to be able to restore the lung’s immune response, enhancing protection, accelerating recovery and countering the impact of SARS-CoV-2 virus,” Professor Tom Wilkinson, Professor of Respiratory Medicine at the University of Southampton, UK, and trial chief investigator.'


“our inhaled treatment of giving high local concentrations of interferon beta, a naturally occurring antiviral protein, restores the lung’s ability to neutralise the virus or any mutation of the virus or co-infection with another respiratory virus such as influenza or RSV, as could be encountered in the winter if there is a resurgence of COVID-19”, said Professor Stephen Holgate, Medical Research Council Clinical Professor of Immunopharmacology at the University of Southampton and co-founder of Synairgen.”